fingolimod hydrochloride has been researched along with harmaline in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (harmaline) | Trials (harmaline) | Recent Studies (post-2010) (harmaline) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 633 | 2 | 125 |
| Protein | Taxonomy | fingolimod hydrochloride (IC50) | harmaline (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 4.9 | |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.012 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.0329 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arjmand, S; Asadi-Shekaari, M; Basiri, M; Dahmardeh, N; Kalantaripour, T; Shabani, M | 1 |
1 other study(ies) available for fingolimod hydrochloride and harmaline
| Article | Year |
|---|---|
Modulation of sphingosine-1-phosphate receptor ameliorates harmaline-induced essential tremor in rat.
Topics: Animals; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Essential Tremor; Fingolimod Hydrochloride; Gait Disorders, Neurologic; Harmaline; Immunosuppressive Agents; Male; Neuroprotective Agents; Rats; Rats, Wistar; Receptors, Lysosphingolipid | 2017 |